Danaher Co. (NYSE:DHR) Shares Sold by Quantum Private Wealth LLC

Quantum Private Wealth LLC reduced its holdings in shares of Danaher Co. (NYSE:DHR) by 4.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,336 shares of the conglomerate’s stock after selling 104 shares during the quarter. Quantum Private Wealth LLC’s holdings in Danaher were worth $536,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Fort Pitt Capital Group LLC grew its holdings in Danaher by 3.2% during the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after acquiring an additional 7,421 shares in the last quarter. Good Life Advisors LLC bought a new position in shares of Danaher during the third quarter worth about $217,000. ORG Partners LLC grew its stake in Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock worth $636,000 after purchasing an additional 2,559 shares in the last quarter. Harvest Portfolios Group Inc. increased its holdings in Danaher by 1.2% in the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after buying an additional 2,465 shares during the last quarter. Finally, Generate Investment Management Ltd acquired a new stake in Danaher during the fourth quarter valued at approximately $8,044,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on DHR shares. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a research report on Friday, December 13th. JPMorgan Chase & Co. decreased their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Stephens reissued an “overweight” rating and set a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Finally, KeyCorp increased their price objective on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Seven research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Stock Performance

DHR stock opened at $206.66 on Friday. The company has a 50-day simple moving average of $229.53 and a 200 day simple moving average of $249.51. The company has a market capitalization of $149.26 billion, a P/E ratio of 39.14, a PEG ratio of 2.68 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period last year, the company posted $2.09 earnings per share. Sell-side analysts predict that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.52%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.